Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AST-MOMA: Modified Stem Cell Transplantation for Systemic Sclerosis
NCT01895244Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Sep 2012
- Primary completion
- Sep 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous cd34-selected peripheral blood stem cells in systemic sclerosis (SSc), sponsored by University Hospital Tübingen. Started Sep 2012; status: completed.
02
Drugs
autologous cd34-selected peripheral blood stem cells
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT01895244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01895244.